DESTINY-Breast03: practice-changing results from ESMO 2021 VJOncology 2:27 3 years ago 537 Далее Скачать
Highlights in Metastatic BreastCancer from ESMO 2022 Oncology Information Group 4:55 2 years ago 23 Далее Скачать
ESMO 2021 breast cancer highlights: TULIP and KEYNOTE-355 VJOncology 2:34 3 years ago 95 Далее Скачать
Highlights on T-DXd in pretreated HER2-expressing solid tumours : The DESTINY-PanTumor02 study European Society for Medical Oncology (ESMO) 2:38 1 year ago 1 194 Далее Скачать
Updated findings of T-DXd in DESTINY-Breast02 at ESMO Breast 2024 VJOncology 3:06 7 months ago 280 Далее Скачать
DESTINY-Breast03: T-DXd is superior to T-DM1 in HER2+ metastatic breast cancer VJOncology 2:48 3 years ago 502 Далее Скачать
Breast and gynecological cancer highlights at ESMO Immuno-Oncology 2022 VJOncology 1:02 2 years ago 81 Далее Скачать
Sara Tolaney, ESMO 2022: Clinical trial highlights in breast cancer Touch Medical Media 2:46 2 years ago 198 Далее Скачать
